The Ortho Show

Hosted by Dr. Scott Sigman – “Jamie Rindler”

This episode is brought to you by OrthoLazer.

Jamie Rindler is the Founder & CEO of Marvel Group. He helps private practice Spine Surgeons attract more ideal patients and referral sources through their exclusive surgical outcome patient warranty.

Marvel Group was founded in 2015 with a simple mission: to protect and empower patients, surgeons, and team members by providing resources that improve spine surgery. They do this to serve patients, not the system. They have grown into one of the most talked-about value added spine device companies in the country, thanks to their innovative programs, products and dedication to customer service.

Topics include:

-Jamie grew up in Dayton, OH and is a graduate of The Ohio State University. He discusses the importance of family, having 6 kids, and the family influence in launching the Marvel Group. He discusses how he came up with the idea of Marvel Group after a personal back surgery experience with financial risk.

-We hear about Marvel Group’s unique marketing initiatives with a surgical outcome patient warranty and how Jamie developed this novel idea in the orthopedic industry. He details how he originally started an insurance company to help bring into the fold of Marvel Group to help support initiatives.

-Marvel Group’s Surgical Stewardship program incentivizes surgeons, treatment facilities, insurance companies and medical device manufacturers to align themselves around producing the best possible outcome for the patient. It’s made possible by providing the patient a refund if a re-operation is needed called the Patient Promise.

-Independent spine surgeons and their facilities have found that patients will seek out the surgeon who offers the Patient Promise because it’s reassuring to know that the surgical team stands behind their work with a money back guarantee. By partnering with Marvel Group, surgeons can focus more on providing high quality patient care and less about growing their businesses.

Find out more about the Marvel Group and Jamie Rindler here.

Hosted by Dr. Scott Sigman – “Dr. Russell Warren”

This episode is brought to you byKoha Health. At Koha Health, their goal is empowering your practice to achieve total financial health.

We have on one of the great leaders in orthopedics for this episode who trained some of the best “who’s who” sports medicine fellows. Dr. Russell Warren joined the Hospital for Special Surgery on January 1, 1977 and served as surgeon-in-chief from 1993 to 2003. Dr. Warren is the also the emeritus team physician for the New York Giants football team.

Topics include:

-After receiving his medical degree from the State University of New York at Syracuse in 1966, he completed a 1-year surgical residency at St. Luke’s Hospital in New York and went on to serve as a Lt. Commander for the U.S. Navy during Vietnam. For his service, Dr. Warren received the U.S. Navy Medal of Commendation in 1969.

-He discusses the evolution of Hospital of Special Surgery during his tenure. When he started, they did about 6,000 cases per year and now up over 35,000 surgeries per year.

-Dr. Warren talks about his role as a Board Member at American Orthopedic Partners, a private equity platform.

Find out more about Dr. Russell Warren here.

Hosted by Dr. Scott Sigman- Dr. Vladyslav Kozanchuk

This episode is brought to you byNational Medical Billing Services, the ASC revenue cycle experts.

This is a special episode with Ukrainian born and bred orthopedic surgeon, Dr. Vladyslav Kozanchuk with specialties in hip, knee and shoulder arthroplasty.

This is one of our most impactful episodes being in the trenches of war in Ukraine. It was a challenge getting Dr. Kozanchuk on for this episode in-between the blackouts and having good cell service to call in. Dr. Kozanchuk showed up to the recording with a smile on his face and immense pride for his country. He says “We won’t surrender. Russia won’t win. We will win.” He discusses the pride for all the soldiers on the front lines and support Ukraine receives globally.

Topics include:

-On our recording day, there are 267 injured soldiers in the ward with a train of another 100 wounded soldiers coming in later that night. With a curfew from 11p-5a, there are some nights Dr. Kozanchuk doesn’t make it home and needs to wait until the curfew is lifted in the morning. In addition to the wounded soldiers, there are ongoing elective surgeries within their National Health Service.

– Dr. Kozanchuk provides a shout out to Dr. Kenji Inaba from Keck Medicine and Dr. Gregory Beilman from University of Minnesota for traveling to his hospital and providing their services during the war.

Find out more about Dr. Vladyslav Kozanchuk here.

Hosted by Dr. Scott Sigman – “Dr. Joaquin Sanchez-Sotelo”

This episode is brought to you byNational Medical Billing Services, the ASC revenue cycle experts.

Joaquin Sanchez-Sotelo, M.D., Ph.D., is a Mayo Clinic physician-scientist who has several areas of interest in orthopedic research. His research interests include surgical conditions affecting the shoulder and elbow joints, the application of artificial intelligence to shoulder and elbow surgery, and strategies in individualized medicine.

-Dr. Sanchez-Sotelo was born in Madrid, Spain. It’s in the family business with his father being an orthopedic surgeon. It was in his blood to go into orthopedics.

-We hear about his path in getting a fellowship at Mayo Clinic after Madrid. It’s our first guest who has received his acceptance for a fellowship through a telegram. He is still at the Mayo Clinic and a lifer there.

-What’s it like working at the Mayo Clinic? It’s non-profit organization run by physicians. Dr. Sanchez-Sotelo says no one really chooses to live in Rochester, Minnesota unless you love Mayo and are centered around patient care.

-Robots are finally coming to the shoulder! This is Dr. Sanchez-Sotelo’s passion and says robots will provide accuracy, precision and improve outcomes for patients.

-What’s the highest honor of his career? His Presidency of American Shoulder and Elbow Surgeons.

Find out more about Dr. Joaquin Sanchez-Sotelo here.

Hosted by Dr. Scott Sigman – Dr. Patrick St. Pierre

This episode is brought to you by National Medical Billing Services, the ASC revenue cycle experts.

Dr Patrick St Pierre is an orthopedic surgeon, shoulder specialist in Rancho Mirage, CA.  He has an amazing 20+ year military career and is a world renowned leader in the Army.

Dr. St. Pierre is a graduate of the United States Military Academy at West Point and the Uniformed Services University of Health Sciences in Bethesda, Maryland. After completing his Orthopedic surgery residency at Madigan Army Medical Center, he completed fellowships in Medical Research at the Walter Reed Army Institute of Research and in Orthopedic Sports Medicine at West Point.

Topics include:

-Dr. St Pierre’s father was in the Air Force and traveled around in his youth. His family is originally from Dr. Sigman’s backyard in Lowell, MA and settled in Massachusetts after his father retired from the Air Force. 

-He was originally drawn to cardiology due to his mother having a heart condition. After studying cadets with ankle injuries and getting experience in the military with orthopedics, it led him to a career in this specialty.

-Dr. St. Pierre is very involved in Sports Medicine and Shoulder research and has been recognized with several international and national awards. He has written numerous articles and book chapters, and has edited four books on Sports Medicine. We discuss one of his breakthrough studies in JBJS on rotator cuff repair.

-What are the innovations in shoulder arthroplasty? Dr. St. Pierre discusses he’s working with a great orthopedic surgeon team at Stryker on a robotic system for the shoulder.

Find out more about Dr. Patrick St. Pierre here.

Hosted by Dr. Scott Sigman – “Dr. Will Kurtz”

This episode is brought to you byTrackableMed, the place to go to help grow your new patient base.

This episode is also brought to you by Heron Therapeutics. Please see full Prescribing Information, including Boxed Warning or visit www.ZYNRELEF.com.

Dr. William B. Kurtz is a board-certified, fellowship-trained orthopedic surgeon who specializes in hip and knee replacements at Tennessee Orthopaedic Alliance.

Dr. Kurtz holds a bachelor’s degree in mechanical engineering from Rice University. He graduated medical school from The University of Texas Southwestern Medical School at Dallas with Alpha Omega Alpha honors distinction. He completed a residency in orthopedic surgery at Vanderbilt University Medical Center, followed by a subspecialty fellowship in adult reconstructive joint surgery at New England Baptist Hospital in Boston.

Topics include:

-His role in Ortho Founders, a place where orthopreneurs can pitch their innovations and gain feedback from other leaders in orthopedics.

-Dr. Will Kurtz is President of Tennessee Orthopaedic Alliance, a group of 106 physicians. He is also a board member in Ortho Forum, whose members comprise 100 private practice groups across the U.S. to share data analysis and best practices on revenue cycle management and ancillary revenue streams.

-He’s done over 10,000 Conformis knees, made specifically for the patient. Dr. Kurtz breaks down the difference between Conformis personalized knees and a standard total knee, which comes off-the-shelf.

-We discuss his recent business case study in Journal Orthopaedic Experience and Innovation, Value Creation vs Value Capture in Orthopedics.

Find out more about Dr. Will Kurtz here.

Also, find out more about Zynrelef here:

ZYNRELEF utilizes a novel synergistic mechanism of action that combines bupivacaine with a low dose of meloxicam to overcome the challenges of the inflammatory process at the surgical site. ZYNRELEF is the first and only extended-release dual-acting local anesthetic (DALA) and delivers 72 hours of postoperative pain relief via a single needle-free application. It has been clinically proven to better manage pain than standard of care bupivacaine HCl solution over 72 hours and to significantly reduce opioid utilization following surgery.

-ZYNRELEF was initially approved by the FDA in May 2021 and in December 2021, the FDA approved an expansion of ZYNRELEF’s indication.

-Limitations of Use: Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures.

WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS

See full prescribing information for complete boxed warning.

• Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use

• ZYNRELEF is contraindicated in the setting of coronary artery bypass graft (CABG) surgery

• NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events

ZYNRELEF is contraindicated for:

• Patients with a known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to any local anesthetic agent of the amide-type, NSAIDs, or to any of the other components of ZYNRELEF OR history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients

• Patients undergoing obstetrical paracervical block anesthesia OR coronary artery bypass graft (CABG) surgery

WARNINGS AND PRECAUTIONS include –

Cardiovascular (CV) Thrombotic Events with NSAID Use; Gastrointestinal Bleeding, Ulceration, and Perforation with NSAID Use; Dose-Related Toxicity; Risk of Use in Patients with Impaired Cardiovascular Function; Hepatotoxicity; Hypertension; Heart Failure and Edema; Renal Toxicity and Hyperkalemia; Anaphylactic Reactions; Chondrolysis; Methemoglobinemia; Exacerbation of Asthma Related to Aspirin Sensitivity; Serious Skin Reactions; Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS); Hematologic Toxicity; Masking of Inflammation and Fever.